Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Alcon acquires Neurotech and its approved Encelto for $550M
Alcon says it will now help take Encelto global and leverage Neurotech's technology to develop more convenient ocular therapies.
Donavyn Coffey
Oct 21, 2026 10:56am
The Next Chapter for AI in Clinical Trials
Brought to you by
Saama
ICER, West Health call out excessive U.S. drug launch prices
Oct 21, 2026 10:36am
Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue
Brought to you by
Bain & Company
CSL taps GSK’s Deborah Waterhouse as CEO in darkest hour
Oct 21, 2026 10:22am
GSK wins groundbreaking FDA green light in chronic hepatitis B
Oct 21, 2026 6:39am
More News
FDA finalizes guidance on prescription drug apps
Oct 20, 2026 5:59pm
Regulatory tracker: Viatris' Ryzumvi lands FDA presbyopia nod
Oct 20, 2026 3:00pm
Samsung Bio blunts impact of strike threat with court ruling
Oct 20, 2026 1:40pm
Antheia, DOD shake on $80M manufacturing loan
Oct 20, 2026 11:35am